Immunovant Director Atul Pande Sells Common Shares Worth $108,000

• Immunovant director Atul Pande sold 3,000 common shares at $36 each on November 11, 2026.
• He also exercised stock options for 3,000 common shares at $8.43 each that day.
• Following the transactions, Pande held 116,731 shares directly, with another 20,000 held indirectly through a trust.
• His remaining directly held stock options covered 62,181 shares, expiring November 19, 2029.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovant Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001764013-26-000126), on November 12, 2026, and is solely responsible for the information contained therein.